Feedback / Questions
NAV-006 - Navrogen
https://www.prnewswire.com/news-releases/navrogen-presents-its-anti-cd20-antibody-nav-006-and-icam-1-refractory-antibody-drug-conjugate-platform-at-the-2024-american-association-for-cancer-research-annual-meeting-302108454.html
Apr 4, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next